What is preventing the use of high path avian flu vaccines?

High path avian influenza has affected close to 170 million birds over the past three years.

USDA is working to combat the virus and lower egg prices through a new strategy, which includes funding for vaccine research.

American Farm Bureau Economist Bernt Nelson spoke with RFD-TV’s Suzanne Alexander about current HPAI vaccines and what is preventing the use of them.

Related Stories
$2 million project tests fogging system to stop the virus in poultry facilities
More than 15 million birds were affected by bird flu, but fewer outbreaks are helping bring egg prices down
Bigger flocks are rebuilding egg and poultry supply.
As spring migration ramps up, USDA officials warn farmers about rising bird flu risks and urge stronger biosecurity measures. Resources are available through APHIS to help protect livestock.
APHIS Veterinary Medical Officer Dr. Chelsey Shiveley discusses USDA’s biosecurity resources available to poultry producers ahead of spring migration, increasing the risk of Highly Pathogenic Avian Influenza (HPAI) threatens commercial flocks.
Pennsylvania Secretary of Agriculture Russell Redding discusses the recent surge in bird flu cases, the state’s expanded biosecurity response and efforts to support poultry producers.